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Abstract We recently published the genomic characterization
of the STAT5A and STAT5B paralogous genes that are located
head to head in the 17q21 chromosome and share large regions
of sequence identity. We here demonstrate by transient in vitro
transfection that STAT5A and STAT5B promoters are able to
direct comparable levels of transcription. The expression of
basal promoters is enhanced after Sp1 up-regulation in HeLa
and SL2 cells while DNA methylation associated to the recruit-
ment of MeCP2 methyl CpG binding protein down-regulates
STAT5A and B promoters by interfering with Sp1-induced tran-
scription. In addition, cross-species sequence comparison identi-
¢ed a bi-directional negative cis-acting regulatory element lo-
cated in the STAT5 intergenic region.
- 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
The STAT5A and STAT5B genes belong to the signal
transducer and activator of transcription (STAT) family of
transcription factors. The family of STAT genes is believed
to have been produced by successive genome duplication and
functional divergence of a single ancestral Stat gene early in
vertebrate evolution [1,2]. A recent duplication of STAT5 is
believed to have given rise to the closely related STAT5A and
STAT5B homologous genes that encode proteins that in hu-
mans are approximately 94% identical, the only consistent
di¡erence between the two proteins residing in a ¢ve amino
acid insertion at the COOH-terminus of STAT5B. The two
STAT5 paralogues are able to homo- or heterodimerize with
each other and subsequently can translocate to the nucleus.
This function is essential for the activity of these transcription
factors [3]. Despite the extensive similarity between the two
STAT5 proteins, recent reports on Stat5a/5b knock-out mice
have demonstrated that individual features are associated with
the disruption of each individual gene. The double STAT5a/
b3=3 knock-out mouse has an impaired response to a number
of cytokines, including erythropoietin, granulocyte-macro-
phage colony-stimulating factor (GM-CSF), interleukin 2
(IL-2) and growth hormone [4,5] and a profound de¢ciency
in peripheral T-cell proliferation. When only the Stat5b gene
is disrupted, the mutant phenotype is quite similar to the one
observed in growth hormone receptor-de¢cient mice, includ-
ing reduced levels of plasma insulin growth factor 1. When
Stat5a is mutated, the single knock-out has a reduced re-
sponse to several cytokines a¡ecting lymphoid lineage, in par-
ticular GM-CSF and IL-2. The divergent phenotypic e¡ect of
the two mutations is also the result of a known tissue-speci¢c
di¡erence in the relative abundance of Stat5a and Stat5b gene
expression [5,6].
We have recently isolated and sequenced both STAT5A and
STAT5B human genes ¢nding that they have a very similar
genomic organization. A CpG island is present at the 5P end
of each STAT5 gene covering the 5P untranslated region
(UTR). More surprisingly the two genes share large regions
of almost identical sequences that diverge among the di¡erent
species indicating a species-speci¢c mechanism of preserva-
tion. Furthermore, we have identi¢ed two alternative 5P exons
in the STAT5B gene, the second of which is not embedded in
a CpG island [7].
The purpose of the present study is to identify and charac-
terize the promoters of the human STAT5A and B genes to
get insights into the mechanism that regulates the di¡erent
levels of expression of these two genes. Cross-species sequence
comparison of human and mouse sequences has revealed the
presence of three conserved regions: two are located in the 5P
£anking region of each STAT5 gene, spanning the CpG is-
lands and the transcriptional start sites; the third is located in
the intergenic region between STAT5A and STAT5B at a
distance of 5200 bp from STAT5B and 3700 bp from STA-
T5A, referred to the transcriptional start sites.
Functional analysis of these predicted UTRs in transient
transfection in both mammalian and Drosophila cells reveals
that the two STAT5 promoters have a quite similar genetic
architecture and that the 5P £anking region of STAT5 con-
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tains important cis-acting elements required for positive and
negative regulation of transcription.
2. Materials and methods
2.1. Cell culture
Human HeLa (cervix epithelioid carcinoma) and HepG2 (hepato-
cellular carcinoma) cell lines were grown in Dulbecco’s modi¢ed Ea-
gle’s medium supplemented with 10% fetal calf serum. Human Jurkat
cells (acute T-cell leukemia) were maintained in RPMI 1640 medium
with 10% fetal calf serum. The media were supplemented with pen-
icillin (100 U/ml), and streptomycin (100 Wg/ml) and the cultures were
propagated at 37‡C in a humidi¢ed 5% CO2 atmosphere. Drosophila
SL2 cells [8], derived from late D. melanogaster embryos, were grown
in Hyclone serum-free medium (HyQ0 CCM3) plus antibiotics at
25‡C.
2.2. Expression plasmid construction
The STAT5A and STAT5B fragments were ampli¢ed by polymer-
ase chain reaction (PCR) from human genomic DNA using the prim-
ers listed in Table 1. Each primer was designed to contain a tail that
includes a speci¢c restriction enzyme sequence (BglII in the 5P primer
and HindIII in the 3P primer). All the fragments were inserted into the
pGL3 Basic Vector (Promega), upstream of the Photinus pyralis lucif-
erase coding sequence (pA1Luc, pA2Luc, pA3Luc, pB4Luc, pB5Luc)
at the restriction sites reported above and in the orientation indicated
in Fig. 3. The generated fragments were sequenced and the orientation
was checked after cloning into the pGL3 vector. In addition, the B4
and B5 fragments from STAT5B were ampli¢ed and cloned also in
the pGL3Enhancer vector that contains the SV40 enhancer positioned
downstream of the luciferase coding sequence (see Fig. 3B). The Inter
1 and Inter 2 regions were ampli¢ed using primers listed in Table 1.
The two ampli¢ed fragments were inserted upstream of the A2 and B5
fragments in pA2Luc and pB5Luc. Direct and inverted orientations in
relation to the transcription start site (see Fig. 5) were obtained in one
case using tailed primers containing the recognition sequences SacI in
the 5P primer and XhoI in the 3P primer and in the other case using
tailed primer containing the recognition sequences for XhoI in the 5P
primer and SacI in the 3P primer. The Inter 1 and Inter 2 regions,
ampli¢ed as described above, were also fused in both orientations
upstream of the NEMO/IKK-Q human promoter in pGL3 Basic vector
(pF4-IKK-QLuc; F. Fusco, unpublished results and [13]). All the gen-
erated fragments were checked by sequence analysis.
2.3. In vitro DNA methylation
The pA2Luc and pB5Luc constructs were treated with the SssI
methylase (New England Biolabs) to obtain methylated DNA; the
reaction was carried out in presence of 5 mM S-adenosylmethionine
in accordance with the manufacturer’s protocols. The methylase re-
action was assessed by gel electrophoresis after HpaII digestion of
DNA. pA2Luc and pB5Luc constructs treated as reported above
but without the SssI methylase were used as controls.
2.4. Transient transfections and luciferase assay
Human cell lines were transiently transfected with chimeric lucifer-
ase constructs. Unless otherwise reported, 1 Wg of DNA was co-trans-
fected with 20 ng of pRL-CMV (Promega) on to approx. 30% con-
£uent cell plate using FuGENE6 reagent (Roche) according to the
manufacturer’s recommended conditions. The pRL-CMV vector con-
tains the Renilla luciferase gene from Renilla reniformis transcribed by
the CMV promoter. Drosophila SL2 cell transfection and pPACSp1
construct were as described [9]. The human MeCP2 expression plas-
mid was kindly provided by S. Kudo [10].
Each plasmid containing di¡erent promoter fragments to be tested
was co-transfected with the pRL-CMV vector in the selected cell line.
Thus, the dual-luciferase system is based on the measurement of both
¢re£y luciferase and Renilla luciferase activities in the same sample.
Fire£y luciferase activity was assayed in a Turner TD2420 luminom-
eter, as well as Renilla luciferase activity. Data are reported as the
ratio of ¢re£y/Renilla arbitrary units/1000 and indicated as relative
luciferase activity in the legends to Figs. 3^5. Each value is the
mean and standard deviation of results from three independent experi-
ments. Statistical elaboration of data was performed using Microsoft
Excel 2000 software.
2.5. Bioinformatic analysis
Genomic sequences spanning the entire STAT5A, STAT5B and the
intergenic region were analyzed using the alignment software m-Vista:
http://www-gsd.lbl.gov/vista/VistaInput that allows you to align two
chosen sequences and to determine the percentage of identity between
them. Conserved segments can be determined choosing a percentage
identity of at least of x% and a length of y bp. These cut-o¡s (x% over
y bp) are speci¢ed by the user. We chose 80% identity and 70 bp
length, as reported in Fig. 1 [11].
CpG islands and relative plot were generated by Microsoft Excel
2000 as previously described [7], the ordinate corresponds to the algo-
rithm used, that is Y= ((1403(9U(A13A2+1.5)2))1:5)/160, where A1
and A2 are the distances of two CpGs along the sequence.
Promoters were predicted with Promoter Scan: http://bimas.dcrt.
nih.gov/molbio/proscan/ [12]. Putative regulatory regions were
scanned to predict transcription factor binding sites with the Genoma-
tix suite: http://www.genomatix.de/.
3. Results
3.1. Computer analysis and transcriptional activity of the
STAT5A and B promoters in HeLa, HepG2 and Jurkat
cell lines
In order to identify conserved non-coding sequences (CNSs)
in the STAT5 genes, we performed pairwise alignment of the
sequence between the two genes (about 11 kb in human) from
human (AC099811: 146 461/160 861) and mouse (AC073918:
100 021/141 301) (about 40 kb in mouse) using the alignment
software m-Vista with a range that allows you to identify
regions which have at least 80% identity and are 70 bp length
(Fig. 1). Three highly conserved regions were identi¢ed: re-
gion I (Figs. 1a and 2a) located between nucleotides 32119
and +1075 in relation to the STAT5A major transcriptional
start site (region I, 38.4% mean identity) ; region II (Figs. 1a
and 2a) located at positions 31690/+1739 (region II, 46.8%
mean identity) from the STAT5B transcriptional start site;
and region III (Figs. 1a and 2b) that contains two fragments
Table 1
PCR primers
Fragment Forward Reverse
A1 5P-gccgagatctgcaggtaatgaaatggaagtc-3P 5P-gccgaagcttgatcctgccaactaagacac-3P
A2 5P-gccgagatctgcaggtaagaaatggaagtc-3P 5P-gccgaagcttaggacgcgccaccgggtc-3P
A3 5P-gccgagatctcctcactccccatctaatac-3P 5P-gccgaagcttgcaggtaagaaatggaagtc-3P
B4/B4Enh 5P-gccgagatctgacccagcgcaggcaact-3P 5P-gccgaagcttcaatgaacataacgcaatat-3P
B5/B5Enh 5P-gccgagatctaaatgtcaccgaagggcaga-3P 5P-gccgaagcttcaatgaacataacgcaatataa-3P
Inter 1 5P-gccggagctctctttccctcagcctaatcc-3P 5P-gccgctcgagaagttctgtgctggtttagg-3P
5P-gccgctcgagtctttccctcagcctaatcc-3P 5P-gccgagctcaagttctgtgctggtttagg-3P
Inter 2 5P-gccgagctctgctgagtctgtgctggctt-3P 5P-gccgctcgagaaggaaggtcaagtcaaggt-3P
5P-gccgctcgagtgctgagtctgtgctggctt-3P 5P-gccgagctcaaggaaggtcaagtcaaggt-3P
Primers used to amplify the region from STAT5A and STAT5B and from region III, Inter 1 and Inter 2. The underlined sequences correspond
to the restriction sites used for the cloning in the pGL3 vectors.
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with extensive mouse/human identity at 35082 (Inter 1, 50%
mean identity) and at 36061 (Inter 2, 50% mean identity)
from the STAT5B transcriptional start site.
Furthermore, in each of the two 5P £anking conserved re-
gions (region I and region II, Fig. 1) a CpG island was iden-
ti¢ed. A CpG island of 23.2%, extending from the 5PUTR and
covering the entire exon 2 of STAT5A for a total length of
690 bp is located in region I ; the other CpG island of 30.2%,
900 bp length covering exon 1a and extending to the putative
promoter of STAT5B is located in region II. Of note, the two
start sites are located at position 3642 bp from ATG on the
STAT5A mRNA and at 3227 bp from the ATG on the
STAT5B mRNA [7].
Region I and region II contain the STAT5A and STAT5B
major transcription start sites, respectively. Both lack TATA
and CAAT positioning elements, and are characterized by
putative binding sites for transcription factors known to ini-
tiate transcription in TATA-less promoters such as Sp1,
CAAT etc. (summarized in Fig. 2). Indeed, Promoter Scan
software analysis assigns to region I and region II the putative
promoters.
Region III contains two sequences of 589 bp (Inter 1) and
1642 bp (Inter 2) long, respectively, that share high identity
with the intergenic mouse Stat5 sequence (Fig. 1).
We analyzed the transcriptional activity directed by region I
and region II in mammalian cells. For this purpose we used
three STAT5A genomic fragments fused to the luciferase re-
porter gene in the pGL3 Basic vector (A1 fragment from
3430 to +244, A2 from 3430 to +1075, A3 from 32119 to
+244, Fig. 3a). In pGL3 Basic we also subcloned two
STAT5B genomic fragments (B4 from +1739 to +100 that
includes the alternative 1b exon, B5 from 31690 to +236,
Fig. 3a). The luciferase diagrams shown in Fig. 3 clearly in-
dicate that the two most active fragments are those containing
the CpG islands and that the STAT5A promoter is more
active than the STAT5B one in all cell lines. In contrast, the
STAT5B alternative promoter (pB4Luc) cannot drive detect-
able luciferase activity. To determine whether the activity of
the STAT5B alternative promoter was too low to be measured
by standard luciferase assay and/or whether any important
regulatory element was lost in our arti¢cial constructs, we
fused the B4 and B5 fragments upstream of the SV40 en-
hancer in the pGL3 Enhancer vector (Fig. 3b). The luciferase
diagram clearly shows that while the transcriptional activity of
Fig. 1. m-Vista alignment of mouse/human genomic sequences (mouse accession number AC073918, human accession number AC099811) span-
ning the STAT5A, STAT5B intergenic region. a: Descriptions of the fragments used in the transient transfection assays: nucleotide positions,
referred to human accession number are as follows: region I, fragment A1=158 858/159 531, fragment A2=158 858/160 364, fragment
A3=157 168/159 531 (total length 3195); region II, fragment B4= 147 961/149 895, fragment B5= 146 488/148 100 (total length 3429 bp); region
III, Inter 1 = 153 287/153 876, Inter 2 = 154 266/155 908 (total length 589 bp, 1642 bp, respectively). b: Human and mouse intergenic region
alignment: m-Vista criteria used are 80% identity for at least 70 bp length. c: CpG distribution and relative plot were generated using Micro-
soft Excel 2000 as previously described [7]
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pB5 Enhancer is strongly enhanced compared to pB5Luc, the
luciferase activity driven by pB4 Enhancer remains undetect-
able.
3.2. E¡ect of methylation on STAT5A and STAT5B promoter
activity in constitutive or Sp1-induced transcription in
HeLa and Drosophila cells
As reported above, we have found that the regions adjacent
to the transcription start site are characterized by a high
amount of GC and putative binding sites for Sp1. To con¢rm
the biological e¡ect of Sp1 on the STAT5A and STAT5B
transcription rate, we performed co-transfection experiment
in Drosophila SL2 cells, which are devoid of Sp1 activity [9].
Some of the STAT5A and STAT5B luciferase-fused con-
structs were co-transfected with Sp1-expressing plasmid
(pPACSp1) in Drosophila cells ; the above constructs were
not co-transfected when used as a control. The luciferase dia-
gram indicates that Sp1 e⁄ciently transactivates the two chi-
meric constructs containing the putative Sp1 binding sites (50-
fold induction for pA2Luc, 30-fold induction for pB5Luc,
Fig. 4a). The basal activity of both STAT5A and STAT5B
promoters in SL2 cells is almost undetectable, thus suggesting
that Sp1 is one of the major transcription factors required for
the activity of these promoters. In Drosophila cells expressing
exogenous Sp1, STAT5A promoter-driven activity is higher
than STAT5B.
Sp1 binding sites are well known to play a key role in the
maintenance of a methylation-free CpG island in housekeep-
ing genes. Therefore, we tested whether Sp1 sites are still bio-
logically active when promoters are methylated. STAT5A and
STAT5B promoters, contained in the plasmids pA2Luc and
pB5Luc respectively, were in vitro methylated by the SssI
CpG methylase before co-transfection with Sp1 in SL2 cells.
The luciferase diagram shows that methylation only slightly
reduces promoter activity for both genes (Fig. 4a). In order to
determine whether methyl CpG binding proteins could inter-
fere with the activity of STAT5A and STAT5B promoters, we
co-transfected Drosophila cells with an expression vector pro-
ducing the human methyl binding protein MeCP2. It is well
known that CpG methylation down-regulates transcription by
preventing the binding of transcription factors to their recog-
nition sequences and that MeCP2 is one such repressor [10].
The luciferase diagram shows that both STAT5A and
STAT5B promoter activity is greatly reduced thus indicating
that the presence of methyl CpG binding protein inhibits Sp1
binding and transcriptional up-regulation (Fig. 4a).
Therefore, we tried to test if the down-regulatory e¡ect of
methylation on the STAT5A and STAT5B promoters was
reproducible in mammalian cells, which endogenously express
both Sp1 and MeCP2. For this purpose the in vitro methyl-
ated pB5Luc and pA2Luc constructs were transfected in
HeLa cells. The luciferase diagram clearly shows that the tran-
scriptional activity of the STAT5A and STAT5B promoters is
substantially reduced by CpG methylation (Fig. 4b).
3.3. Functional analysis of conserved CNSs located in region
III
In order to de¢ne if the two conserved CNSs located in
region III (Fig. 1) have any regulatory role in the transcription
driven by the two divergent STAT5 promoters, we fused the
Inter 1 and Inter 2 regions upstream of the A2 and B5 frag-
ments in pA2Luc and pB5Luc constructs, respectively, in both
orientations (Fig. 5). We found that both Inter 1 and Inter 2
sequences exert a strong orientation-independent negative ef-
Fig. 2. Analysis of the putative transcriptional binding sites present in the STAT5A and STAT5B promoters and in Inter 1 and Inter 2. a: Re-
gion I and region II corresponding to the STAT5A and STAT5B promoters, respectively. The positions are numbered relative to major tran-
scription start sites that are located at position 3642 bp from ATG on STAT5A mRNA and at 3227 bp from the ATG on STAT5B. b: Bind-
ing sites on the Inter 1 and Inter 2 sequences. The regions of 100% human/mouse identity are boxed.
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fect on the transcription driven by STAT5 promoters (Fig. 5).
This result is not surprising because this region presents a high
density of binding sites for negative transcriptional regulators
when subjected to in silico analysis with the Genomatix suite
(Fig. 2b). Furthermore, we inserted the Inter 1 and Inter 2
sequences in both orientations upstream of the IKK-Q human
promoter in pGL3 vector. This fragment contains the human
IKK-Q promoter region spanning from 31089 to +79 (in rela-
tion to the transcription start site in exon 1a) (Fig. 5b) [13].
We found that the Inter 1 and Inter 2 regions, in both ori-
entations, can down-regulate this promoter that has a tran-
scriptional activity stronger (six-fold higher) than STAT5A.
4. Discussion
In this paper, we report the ¢rst functional characterization
of the 5P £anking region of both STAT5A and STAT5B hu-
man genes and their transcriptional activity in mammalian
and Drosophila SL2 cells. In order to identify sequences that
might have a cis-acting regulatory role, we searched for con-
served regions in the 5P £anking region of these genes. The
two human genes lie head to head at a distance of 11 kb;
therefore we screened the entire region comprised between
them comparing human and mouse sequences. This analysis
revealed three highly conserved upstream CNSs, which are
Fig. 3. Transcriptional activity of the STAT5A and STAT5B promoters in HeLa, HepG2 and Jurkat cells. a: Di¡erent constructs spanning the
STAT5A or STAT5B promoters activate luciferase. b: Luciferase activity driven by fragments B4 and B5 inserted in pGL3 Basic vector or
pGL3 Enhancer vector in HeLa cells. Empty vectors (pGL3, pGL3E) were used as controls. Relative luciferase activity corresponds to the ratio
¢re£y/Renilla activity/1000 for each data point. The results represent the averagesUS.D. of at least three independent experiments. The arrows
indicate the +1 transcriptional start site.
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3195 bp (region I), 3429 bp (region II) and 2400 bp (region III)
long, respectively. The STA5A promoter is predicted in region
I and the STAT5B promoter in region II. Region III is located
3380 bp from the STAT5A transcriptional start site (5082 bp
from STAT5B) and contains two speci¢c sequences (Inter 1
and Inter 2) that share a high level of identity with a region
located between the murine Stat5 genes (see Fig. 1). Putative
recognition sequences for the transcription factors Sp1,
GATA, and NF-UB were identi¢ed in both mouse and human
STAT5 promoter sequences (region I and region II), while
TATA and CAAT positioning elements were absent (see
Fig. 2). A CpG island was identi¢ed in both STAT5A and
STAT5B promoters.
Functional analysis of the predicted CNSs by transient
transfection in HeLa, Jurkat and HepG2 mammalian cells,
as well as in Drosophila SL2 cells, using the luciferase reporter
system, reveals some interesting features of the STAT5 pro-
moters.
1. First, we demonstrate that the region just upstream of the
transcription start sites of the STAT5A and STAT5B genes
possesses promoter activity when placed 5P adjacent to the
reporter luciferase gene and that the CpG island is required
in both promoters for the basal transcriptional activity.
2. STAT5A and B promoter-directed transcription is com-
parable in all cells tested. Indeed, prediction of binding
sites failed to reveal among them any substantial qualita-
tive and quantitative di¡erence in composition of the pu-
tative sites.
3. Sp1, which is the most frequent site observed on both
STAT5 promoters, is a strong activator of STAT5A and
STAT5B transcription in Drosophila SL2 cells. There-
fore, Sp1 is the major determinant of STAT5 gene tran-
scription.
4. Both STAT5A and STAT5B promoters are down-regulated
by DNA methylation and recruitment of MeCP2 methyl
binding protein. The transcriptional down-regulation is de-
tectable in HeLa cells expressing endogenous MeCP2 as
well as in SL2 cells expressing exogenous human MeCP2
and Sp1. Thus we may hypothesize that a cell/stage-speci¢c
regulation of STAT5A and STAT5B expression could be
epigenetically determined and maintained through DNA
methylation.
5. Finally, the conserved intergenic region III that contains
several putative negative regulatory binding sites such as
GAPB, GFl1, ECAT/NFY, BCL6, AREB6, YY1, does in-
deed exert a strong orientation-independent cis-negative
e¡ect on the transcription driven by the STAT5A and B
promoters. This region is also able to exert orientation-in-
dependent down-regulation on a heterologous promoter. It
is worth noting that several of the predicted repressors such
as Ikaros1, POZ/zinc ¢nger (BCL-6), GF1-IB have a role
in normal lymphoid development [14,15].
In conclusion, ¢rst insights into the regulation of human
STAT5A and STAT5B expression are produced by coupling
scanning of their entire intergenic sequence with bioinformatic
tools, to in vitro promoter functional assay. These ¢ndings
should promote a better understanding of the molecular basis
for variations of the reciprocal STAT5A and STAT5B expres-
sion in various human tissues as well as a deeper analysis of
the methylation status of these two genes in speci¢c develop-
mental stages/tissues. For instance, Buitenhuis et al. [16] have
recently demonstrated down-regulation of expression of both
Fig. 4. Transcriptional activity of methylated STAT5A and STAT5B promoters. a: Methylated pA2Luc and pB5Luc were transiently co-trans-
fected in SL2 cells with indicated expression plasmids (Sp1, MeCP2); unmethylated DNA was used as control. b: Methylation of pA2Luc and
pB5Luc fragments eliminates the luciferase activity in HeLa cells. The data represent the averagesU S.D. of at least three independent experi-
ments.
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STAT5s during the ¢nal stage of eosinophil di¡erentiation,
thus suggesting a critical role for these genes in human pri-
mary hematopoietic cell di¡erentiation. However, the molec-
ular mechanism underlying the down-regulation of STAT5s
remains largely unexplored.
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